Pear Therapeutics (PEAR)
US Market

Pear Therapeutics (PEAR) Stock Price & Analysis


PEAR Stock Chart & Stats

Day’s Range$0.03 - $0.042
52-Week Range― - ―
Previous Close$0.05
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding142,739,169
10 Day Avg. Volume6,351,234
30 Day Avg. Volume3,199,214
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)1.05
Price to Sales (P/S)1.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside15310.96% Upside
Rating ConsensusHold
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Pear Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Pear Therapeutics’s market cap?
Currently, no data Available
When is Pear Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pear Therapeutics’s earnings last quarter?
Currently, no data Available
Is Pear Therapeutics overvalued?
According to Wall Street analysts Pear Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Pear Therapeutics pay dividends?
    Pear Therapeutics does not currently pay dividends.
    What is Pear Therapeutics’s EPS estimate?
    Pear Therapeutics’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Pear Therapeutics have?
    Currently, no data Available
    What happened to Pear Therapeutics’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Pear Therapeutics?
    Among the largest hedge funds holding Pear Therapeutics’s share is Perceptive Advisors LLC. It holds Pear Therapeutics’s shares valued at 1M.


      Pear Therapeutics Stock Smart Score

      This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
      Learn more about TipRanks Smart Score

      Company Description

      Pear Therapeutics

      Thimble Point Acquisition Corp is a blank check company. it is formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business.


      Top 5 ETFs holding PEAR

      Market Value
      Smart Score
      Vanguard Total Stock Market ETF
      Vanguard Russell 3000 ETF
      Up to five ETFs with an Outperform Smart Score that hold PEAR. The ETFs are listed according to market value of PEAR within the ETF

      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Health Catalyst
      Computer Programs and Systems

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis